Clinical trial
Combination Chemotherapy With or Without Etoposide Followed By an Autologous…
NCT00392886 · Children's Hospital Los Angeles, Other · Unknown status
Key facts
| NCT number | NCT00392886 |
|---|---|
| Title | Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors |
| Official title | Dose Intensive Chemotherapy for Children Less Than Ten Years of Age Newly-Diagnosed With Malignant Brain Tumors: A Pilot Study of Two Alternative Intensive Induction Chemotherapy Regimens, Followed by Consolidation With Myeloablative Chemotherapy (Thiotepa and Carboplatin, With or Without Etoposide)… |
| Lead sponsor | Children's Hospital Los Angeles, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | carboplatin, cisplatin, cyclophosphamide, etoposide, methotrexate, temozolomide, thiotepa, vincristine sulfate, autologous bone marrow transplantation, autologous hematopoietic stem cell transplantation and 2 more |
| Enrollment | 120 |
| Start date | Mar 1, 2004 |
| Primary completion | Dec 1, 2010 |
| First posted | Oct 26, 2006 |
| Last update posted | Dec 18, 2013 |
| Countries | Australia, Canada, New Zealand, Switzerland, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: